According to Pfizer’s CEO, a fourth dose of the Covid-19 vaccine will be required, but the company is working to treat all variants.

“Many variants have emerged and Omicron was the first variant to successfully circumvent the immune protection we are giving,” Bula told CBS’s “Face the Nation.”

“The protection we get from the third dose (dose) is good enough-it’s actually pretty good for hospitalization and death,” Bourla said.

However, protection after three doses is “not very good against infection” and “doesn’t last very long” when faced with mutants like Omicron.

“For now, we need a quarter (dose),” Bula told CBS.

Currently, people over the age of 12 who received a second dose of Pfizer vaccine at least 5 months ago can receive a third dose.

According to the US Centers for Disease Control and Prevention, people over the age of 18 who have been vaccinated with the two-dose Moderna vaccine should receive a booster six months after the second vaccination.

According to the CDC, those who have been vaccinated with a single Johnson & Johnson vaccine should receive a booster two months later.

According to the CDC, people with moderate or severe immunodeficiency who have been vaccinated with Pfizer / BioNTech or Moderna Covid-19 vaccine three times can already receive a fourth vaccination.

However, it is not clear if and when the US Food and Drug Administration will allow healthy teens and adults to receive a fourth dose of the Covid-19 vaccine.

“We’re submitting these data to the FDA so we can see what the experts say outside of Pfizer,” Bula told CBS.

Children under the age of 5 may be able to get vaccinated immediately

Currently, children between the ages of 5 and 11 are eligible for two pediatric doses of Pfizer’s Covid-19 vaccine, but not yet as boosters. Pfizer is currently testing a third dose in that age group.

And children under the age of five are not yet eligible for the Covid-19 vaccine-which may change this spring, Bourla said.

Initial study data on children aged 2 to 5 showed that infants aged 2 to 5 years were expected to be immune in infants aged 6 months to 2 years, but child-sized vaccines aged 2 to 5 years. It was shown that the expected immunity was not obtained even after two doses. ..
Therefore, Pfizer decided to add a third child-sized dose to children under the age of 5 in an ongoing study.

Bourla told CBS on Sunday that Pfizer needs to obtain data on a triple-dose vaccine trial in children aged 6 months to 5 years by April.

If approved by the FDA and recommended by the CDC, the Covid-19 vaccine for children aged 6 months to 5 years could be launched as early as May, Bourla said.

Long-lasting vaccine shots for all variants

Pfizer and Moderna say they are working on a vaccine that specifically protects against Omicron variants, but it is not yet clear if it is needed.

Pfizer also wants to produce a vaccine that protects against Omicron and all other variants of SARS-CoV-2, the virus that causes Covid-19, Bula said.

The goal is to create something that can be protected for at least a year, Bula told CBS on Sunday.

“And if we can achieve that, I think it’s very easy to follow and remember so that we can really go back to our previous lives,” he said. Told.

CNN’s Jacqueline Howard contributed to this report.


About the author


Leave a Comment